financetom
Business
financetom
/
Business
/
Uranium Royalty Up 5.5% After Hours as it Renews an At-the-Market Equity Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uranium Royalty Up 5.5% After Hours as it Renews an At-the-Market Equity Program
Aug 20, 2025 2:08 PM

04:53 PM EDT, 08/20/2025 (MT Newswires) -- Uranium Royalty ( UROY ) was last seen up 5.5% in after-hours Nasdaq trading after the company on Wednesday it renewed its at-the-market (ATM) equity program, allowing it sell up to US$54 million in shares.

The program allows the company, which says it is the world's only uranium-focused royalty and streaming company, to raise funds by selling shares at its discretion at prevailing market prices.

Uranium Royalty ( UROY ) intends to use the proceeds to finance the acquisition of additional royalties, streams, physical uranium and similar interests, and for working capital purposes.

The company's shares were last seen up US$0.14 to US$2.70 after hours. They closed down $0.13 to $3.54 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gap Insider Sold Shares Worth $704,603, According to a Recent SEC Filing
Gap Insider Sold Shares Worth $704,603, According to a Recent SEC Filing
Mar 18, 2024
10:13 AM EDT, 03/18/2024 (MT Newswires) -- Sarah Gilligan, Chief Sup Chn & Transform Ofcr, on March 14, 2024, sold 31,167 shares in Gap (GPS) for $704,603. SEC Filing: https://www.sec.gov/Archives/edgar/data/39911/000003991124000041/xslF345X03/edgardoc.xml Price: 24.57, Change: +0.98, Percent Change: +4.15 ...
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Mar 18, 2024
Friday, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted positively (8-3) favoring expanded use of Bristol Myers Squibb & Co ( BMY )  2seventy bio Inc’s  Abecma (idecabtagene vicleucel). The panel said Abecma demonstrated a favorable benefit/risk profile for patients with triple-class exposed relapsed or refractory multiple myeloma based on the pivotal Phase 3 KarMMa-3 study results, including the key secondary endpoint of overall...
Update: Nuvei Confirms Considering Expressions of Interest, Other Options; RBC Says Timing of Talks 'Made Sense'; Up over 25% in US, Canada Trading
Update: Nuvei Confirms Considering Expressions of Interest, Other Options; RBC Says Timing of Talks 'Made Sense'; Up over 25% in US, Canada Trading
Mar 18, 2024
10:14 AM EDT, 03/18/2024 (MT Newswires) -- Nuvei Corp. ( NVEI ) announced overnight Sunday that it is aware of recent media reports speculating as to a potential going-private transaction involving the company. This comes after Reuters on Saturday cited a source familiar with the matter as saying private equity firm Advent International is in advanced talks to buy Nuvei...
Why Canoo (GOEV) Stock Is Skyrocketing
Why Canoo (GOEV) Stock Is Skyrocketing
Mar 18, 2024
Canoo Inc ( GOEV ) shares are trading higher by 56% to $3.03 during Monday’s session after the U.S. Department of Commerce has approved its Oklahoma City facility as a Foreign Trade Zone. The company says FTZ designation enables Canoo ( GOEV ) to eliminate customs duties on vehicles sold internationally and defer duties on imported parts used in domestic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved